GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration
• A GC-MSMS method was first developed and validated for quantification of sclareol. • Pharmacokinetic characteristic of sclareol were firstly obtained. • Liquid-liquid extraction with ethyl acetate can obtain a higher response.
Gespeichert in:
| Autor*in: |
Xiang, Zheng [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years - Pannek, Kerstin ELSEVIER, 2020, New York, NY [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:1173 ; year:2021 ; day:30 ; month:05 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jchromb.2021.122703 |
|---|
| Katalog-ID: |
ELV054101638 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV054101638 | ||
| 003 | DE-627 | ||
| 005 | 20230624204454.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jchromb.2021.122703 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001398.pica |
| 035 | |a (DE-627)ELV054101638 | ||
| 035 | |a (ELSEVIER)S1570-0232(21)00183-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a LING |q DE-30 |2 fid | ||
| 084 | |a 44.64 |2 bkl | ||
| 084 | |a 44.90 |2 bkl | ||
| 100 | 1 | |a Xiang, Zheng |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration |
| 264 | 1 | |c 2021 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • A GC-MSMS method was first developed and validated for quantification of sclareol. • Pharmacokinetic characteristic of sclareol were firstly obtained. • Liquid-liquid extraction with ethyl acetate can obtain a higher response. | ||
| 650 | 7 | |a Sclareol |2 Elsevier | |
| 650 | 7 | |a GC-MS/MS |2 Elsevier | |
| 650 | 7 | |a Pharmacokinetics |2 Elsevier | |
| 700 | 1 | |a Chen, Yuanyuan |4 oth | |
| 700 | 1 | |a Xiao, Qiming |4 oth | |
| 700 | 1 | |a Yu, Xinwei |4 oth | |
| 700 | 1 | |a Yu, Xixi |4 oth | |
| 700 | 1 | |a Hu, Zhiyan |4 oth | |
| 700 | 1 | |a Wang, Chaojie |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Science Direct |a Pannek, Kerstin ELSEVIER |t Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years |d 2020 |g New York, NY [u.a.] |w (DE-627)ELV005216222 |
| 773 | 1 | 8 | |g volume:1173 |g year:2021 |g day:30 |g month:05 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jchromb.2021.122703 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-LING | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.64 |j Radiologie |q VZ |
| 936 | b | k | |a 44.90 |j Neurologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 1173 |j 2021 |b 30 |c 0530 |h 0 | ||
| author_variant |
z x zx |
|---|---|
| matchkey_str |
xiangzhengchenyuanyuanxiaoqimingyuxinwei:2021----:cssehdodtriainnpamckntcoslroirtlsafe |
| hierarchy_sort_str |
2021 |
| bklnumber |
44.64 44.90 |
| publishDate |
2021 |
| allfields |
10.1016/j.jchromb.2021.122703 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001398.pica (DE-627)ELV054101638 (ELSEVIER)S1570-0232(21)00183-5 DE-627 ger DE-627 rakwb eng 610 VZ LING DE-30 fid 44.64 bkl 44.90 bkl Xiang, Zheng verfasserin aut GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • A GC-MSMS method was first developed and validated for quantification of sclareol. • Pharmacokinetic characteristic of sclareol were firstly obtained. • Liquid-liquid extraction with ethyl acetate can obtain a higher response. Sclareol Elsevier GC-MS/MS Elsevier Pharmacokinetics Elsevier Chen, Yuanyuan oth Xiao, Qiming oth Yu, Xinwei oth Yu, Xixi oth Hu, Zhiyan oth Wang, Chaojie oth Enthalten in Science Direct Pannek, Kerstin ELSEVIER Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years 2020 New York, NY [u.a.] (DE-627)ELV005216222 volume:1173 year:2021 day:30 month:05 pages:0 https://doi.org/10.1016/j.jchromb.2021.122703 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING SSG-OLC-PHA 44.64 Radiologie VZ 44.90 Neurologie VZ AR 1173 2021 30 0530 0 |
| spelling |
10.1016/j.jchromb.2021.122703 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001398.pica (DE-627)ELV054101638 (ELSEVIER)S1570-0232(21)00183-5 DE-627 ger DE-627 rakwb eng 610 VZ LING DE-30 fid 44.64 bkl 44.90 bkl Xiang, Zheng verfasserin aut GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • A GC-MSMS method was first developed and validated for quantification of sclareol. • Pharmacokinetic characteristic of sclareol were firstly obtained. • Liquid-liquid extraction with ethyl acetate can obtain a higher response. Sclareol Elsevier GC-MS/MS Elsevier Pharmacokinetics Elsevier Chen, Yuanyuan oth Xiao, Qiming oth Yu, Xinwei oth Yu, Xixi oth Hu, Zhiyan oth Wang, Chaojie oth Enthalten in Science Direct Pannek, Kerstin ELSEVIER Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years 2020 New York, NY [u.a.] (DE-627)ELV005216222 volume:1173 year:2021 day:30 month:05 pages:0 https://doi.org/10.1016/j.jchromb.2021.122703 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING SSG-OLC-PHA 44.64 Radiologie VZ 44.90 Neurologie VZ AR 1173 2021 30 0530 0 |
| allfields_unstemmed |
10.1016/j.jchromb.2021.122703 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001398.pica (DE-627)ELV054101638 (ELSEVIER)S1570-0232(21)00183-5 DE-627 ger DE-627 rakwb eng 610 VZ LING DE-30 fid 44.64 bkl 44.90 bkl Xiang, Zheng verfasserin aut GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • A GC-MSMS method was first developed and validated for quantification of sclareol. • Pharmacokinetic characteristic of sclareol were firstly obtained. • Liquid-liquid extraction with ethyl acetate can obtain a higher response. Sclareol Elsevier GC-MS/MS Elsevier Pharmacokinetics Elsevier Chen, Yuanyuan oth Xiao, Qiming oth Yu, Xinwei oth Yu, Xixi oth Hu, Zhiyan oth Wang, Chaojie oth Enthalten in Science Direct Pannek, Kerstin ELSEVIER Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years 2020 New York, NY [u.a.] (DE-627)ELV005216222 volume:1173 year:2021 day:30 month:05 pages:0 https://doi.org/10.1016/j.jchromb.2021.122703 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING SSG-OLC-PHA 44.64 Radiologie VZ 44.90 Neurologie VZ AR 1173 2021 30 0530 0 |
| allfieldsGer |
10.1016/j.jchromb.2021.122703 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001398.pica (DE-627)ELV054101638 (ELSEVIER)S1570-0232(21)00183-5 DE-627 ger DE-627 rakwb eng 610 VZ LING DE-30 fid 44.64 bkl 44.90 bkl Xiang, Zheng verfasserin aut GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • A GC-MSMS method was first developed and validated for quantification of sclareol. • Pharmacokinetic characteristic of sclareol were firstly obtained. • Liquid-liquid extraction with ethyl acetate can obtain a higher response. Sclareol Elsevier GC-MS/MS Elsevier Pharmacokinetics Elsevier Chen, Yuanyuan oth Xiao, Qiming oth Yu, Xinwei oth Yu, Xixi oth Hu, Zhiyan oth Wang, Chaojie oth Enthalten in Science Direct Pannek, Kerstin ELSEVIER Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years 2020 New York, NY [u.a.] (DE-627)ELV005216222 volume:1173 year:2021 day:30 month:05 pages:0 https://doi.org/10.1016/j.jchromb.2021.122703 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING SSG-OLC-PHA 44.64 Radiologie VZ 44.90 Neurologie VZ AR 1173 2021 30 0530 0 |
| allfieldsSound |
10.1016/j.jchromb.2021.122703 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001398.pica (DE-627)ELV054101638 (ELSEVIER)S1570-0232(21)00183-5 DE-627 ger DE-627 rakwb eng 610 VZ LING DE-30 fid 44.64 bkl 44.90 bkl Xiang, Zheng verfasserin aut GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • A GC-MSMS method was first developed and validated for quantification of sclareol. • Pharmacokinetic characteristic of sclareol were firstly obtained. • Liquid-liquid extraction with ethyl acetate can obtain a higher response. Sclareol Elsevier GC-MS/MS Elsevier Pharmacokinetics Elsevier Chen, Yuanyuan oth Xiao, Qiming oth Yu, Xinwei oth Yu, Xixi oth Hu, Zhiyan oth Wang, Chaojie oth Enthalten in Science Direct Pannek, Kerstin ELSEVIER Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years 2020 New York, NY [u.a.] (DE-627)ELV005216222 volume:1173 year:2021 day:30 month:05 pages:0 https://doi.org/10.1016/j.jchromb.2021.122703 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING SSG-OLC-PHA 44.64 Radiologie VZ 44.90 Neurologie VZ AR 1173 2021 30 0530 0 |
| language |
English |
| source |
Enthalten in Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years New York, NY [u.a.] volume:1173 year:2021 day:30 month:05 pages:0 |
| sourceStr |
Enthalten in Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years New York, NY [u.a.] volume:1173 year:2021 day:30 month:05 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Radiologie Neurologie |
| institution |
findex.gbv.de |
| topic_facet |
Sclareol GC-MS/MS Pharmacokinetics |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years |
| authorswithroles_txt_mv |
Xiang, Zheng @@aut@@ Chen, Yuanyuan @@oth@@ Xiao, Qiming @@oth@@ Yu, Xinwei @@oth@@ Yu, Xixi @@oth@@ Hu, Zhiyan @@oth@@ Wang, Chaojie @@oth@@ |
| publishDateDaySort_date |
2021-01-30T00:00:00Z |
| hierarchy_top_id |
ELV005216222 |
| dewey-sort |
3610 |
| id |
ELV054101638 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV054101638</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624204454.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jchromb.2021.122703</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001398.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV054101638</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1570-0232(21)00183-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">LING</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.64</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.90</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Xiang, Zheng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• A GC-MSMS method was first developed and validated for quantification of sclareol. • Pharmacokinetic characteristic of sclareol were firstly obtained. • Liquid-liquid extraction with ethyl acetate can obtain a higher response.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sclareol</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GC-MS/MS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacokinetics</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Yuanyuan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Xiao, Qiming</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yu, Xinwei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yu, Xixi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hu, Zhiyan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Chaojie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Science Direct</subfield><subfield code="a">Pannek, Kerstin ELSEVIER</subfield><subfield code="t">Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years</subfield><subfield code="d">2020</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV005216222</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1173</subfield><subfield code="g">year:2021</subfield><subfield code="g">day:30</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jchromb.2021.122703</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-LING</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.64</subfield><subfield code="j">Radiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.90</subfield><subfield code="j">Neurologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1173</subfield><subfield code="j">2021</subfield><subfield code="b">30</subfield><subfield code="c">0530</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Xiang, Zheng |
| spellingShingle |
Xiang, Zheng ddc 610 fid LING bkl 44.64 bkl 44.90 Elsevier Sclareol Elsevier GC-MS/MS Elsevier Pharmacokinetics GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration |
| authorStr |
Xiang, Zheng |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV005216222 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ LING DE-30 fid 44.64 bkl 44.90 bkl GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration Sclareol Elsevier GC-MS/MS Elsevier Pharmacokinetics Elsevier |
| topic |
ddc 610 fid LING bkl 44.64 bkl 44.90 Elsevier Sclareol Elsevier GC-MS/MS Elsevier Pharmacokinetics |
| topic_unstemmed |
ddc 610 fid LING bkl 44.64 bkl 44.90 Elsevier Sclareol Elsevier GC-MS/MS Elsevier Pharmacokinetics |
| topic_browse |
ddc 610 fid LING bkl 44.64 bkl 44.90 Elsevier Sclareol Elsevier GC-MS/MS Elsevier Pharmacokinetics |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
y c yc q x qx x y xy x y xy z h zh c w cw |
| hierarchy_parent_title |
Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years |
| hierarchy_parent_id |
ELV005216222 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV005216222 |
| title |
GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration |
| ctrlnum |
(DE-627)ELV054101638 (ELSEVIER)S1570-0232(21)00183-5 |
| title_full |
GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration |
| author_sort |
Xiang, Zheng |
| journal |
Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years |
| journalStr |
Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Xiang, Zheng |
| container_volume |
1173 |
| class |
610 VZ LING DE-30 fid 44.64 bkl 44.90 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Xiang, Zheng |
| doi_str_mv |
10.1016/j.jchromb.2021.122703 |
| dewey-full |
610 |
| title_sort |
gc-ms/ms method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration |
| title_auth |
GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration |
| abstract |
• A GC-MSMS method was first developed and validated for quantification of sclareol. • Pharmacokinetic characteristic of sclareol were firstly obtained. • Liquid-liquid extraction with ethyl acetate can obtain a higher response. |
| abstractGer |
• A GC-MSMS method was first developed and validated for quantification of sclareol. • Pharmacokinetic characteristic of sclareol were firstly obtained. • Liquid-liquid extraction with ethyl acetate can obtain a higher response. |
| abstract_unstemmed |
• A GC-MSMS method was first developed and validated for quantification of sclareol. • Pharmacokinetic characteristic of sclareol were firstly obtained. • Liquid-liquid extraction with ethyl acetate can obtain a higher response. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-LING SSG-OLC-PHA |
| title_short |
GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration |
| url |
https://doi.org/10.1016/j.jchromb.2021.122703 |
| remote_bool |
true |
| author2 |
Chen, Yuanyuan Xiao, Qiming Yu, Xinwei Yu, Xixi Hu, Zhiyan Wang, Chaojie |
| author2Str |
Chen, Yuanyuan Xiao, Qiming Yu, Xinwei Yu, Xixi Hu, Zhiyan Wang, Chaojie |
| ppnlink |
ELV005216222 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/j.jchromb.2021.122703 |
| up_date |
2024-07-06T20:46:56.280Z |
| _version_ |
1803864051580665856 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV054101638</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624204454.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jchromb.2021.122703</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001398.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV054101638</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1570-0232(21)00183-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">LING</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.64</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.90</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Xiang, Zheng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• A GC-MSMS method was first developed and validated for quantification of sclareol. • Pharmacokinetic characteristic of sclareol were firstly obtained. • Liquid-liquid extraction with ethyl acetate can obtain a higher response.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sclareol</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GC-MS/MS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacokinetics</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Yuanyuan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Xiao, Qiming</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yu, Xinwei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yu, Xixi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hu, Zhiyan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Chaojie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Science Direct</subfield><subfield code="a">Pannek, Kerstin ELSEVIER</subfield><subfield code="t">Brain microstructure and morphology of very preterm-born infants at term equivalent age: Associations with motor and cognitive outcomes at 1 and 2 years</subfield><subfield code="d">2020</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV005216222</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1173</subfield><subfield code="g">year:2021</subfield><subfield code="g">day:30</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jchromb.2021.122703</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-LING</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.64</subfield><subfield code="j">Radiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.90</subfield><subfield code="j">Neurologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1173</subfield><subfield code="j">2021</subfield><subfield code="b">30</subfield><subfield code="c">0530</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.40028 |